SARAH MENKE: Open Payments
NPI 1982093613 · WESTBROOK, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$459 in 17 payments from 12 companies in 2025. Trend: 2023 $451 · 2024 $270 · 2025 $459
Food & beverage: $459
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $135 |
| Janssen Biotech, Inc. | 2 | $59 |
| Novocure Inc. | 1 | $41 |
| Merck Sharp & Dohme LLC | 2 | $37 |
| Astellas Pharma US Inc | 1 | $29 |
| AstraZeneca Pharmaceuticals LP | 1 | $27 |
| GENZYME CORPORATION | 1 | $26 |
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
| Daiichi Sankyo Inc. | 1 | $24 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
Products named: EPKINLY, ERLEADA, Optune Lua (NovoTTF-200T), KEYTRUDA, Xtandi, ENHERTU, WAYRILZ, OPDIVO.
Industry payments across ME — which companies pay providers there.
